Organon Pharma Indonesia Tbk. vs Triputra Agro Persada Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Triputra Agro Persada Tbk. trades at Rp2,270 (market cap 44.67T, 12.99M 24h volume). The key difference: Triputra Agro Persada Tbk. is far larger — about 427.9× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | TAPG | |
|---|---|---|
Market Cap | 104.4B | 44.67T |
Volume | — | 12.99M |
Lot | — | 129.93K |
Turnover | — | 29.27B |
Average Price | — | 2,252.84 |
Value | — | 29.27B |
Indicative Equilibrium Price | — | 2,270 |
Indicative Equilibrium Volume | — | 4.05K |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →PT Triputra Agro Persada Tbk (the Company) was established under the name of PT Alam Permata Indah based on Notarial Deed No. 4 of Ir. Rusli, S.H., dated January 24, 2005. In 2005, the Company through its Subsidiaries carried out trading business activities, development, industry and agriculture by acquiring PT Brahma Binabakti and PT Kirana Sekernan which is engaged in oil palm plantations, the palm oil processing industry and rubber plantation.
Read more on TAPG →